Imbrium Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Imbrium Therapeutics's estimated annual revenue is currently $5.7M per year.(i)
  • Imbrium Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Imbrium Therapeutics has 37 Employees.(i)
  • Imbrium Therapeutics grew their employee count by 0% last year.

Imbrium Therapeutics's People

NameTitleEmail/Phone
1
Director, PharmaceuticsReveal Email/Phone
2
Executive Director, Pharmaceutics and Analytical DevelopmentReveal Email/Phone
3
Executive Director, Licensing & Business DevelopmentReveal Email/Phone
4
Sr. DirectorReveal Email/Phone
5
Executive Director Regulatory AffairsReveal Email/Phone
6
Director, Regulatory StrategyReveal Email/Phone
7
Executive Director Strategic Projects & Business InitiativesReveal Email/Phone
8
Director, Analytical Research and DevelopmentReveal Email/Phone
9
Clinical Compliance ManagerReveal Email/Phone
10
Manager, Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-80%N/AN/A
#2
$4.3M288%N/AN/A
#3
$9.8M66-11%N/AN/A
#4
$1.4M9350%N/AN/A
#5
$16.6M107-23%N/AN/A
#6
$4.5M29-22%N/AN/A
#7
$1.7M1157%N/AN/A
#8
$2.3M15-6%N/AN/A
#9
$0.3M4-43%N/AN/A
#10
$4M260%N/AN/A
Add Company

What Is Imbrium Therapeutics?

Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. As an operating subsidiary of Purdue Pharma L.P., Imbrium strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians and health systems worldwide. We have built a robust and diversified pipeline of investigational drug candidates, and we actively collaborate with industry and academic partners to identify and advance future impactful medicines.

keywords:N/A

N/A

Total Funding

37

Number of Employees

$5.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M37-3%N/A
#2
$7.5M37-16%N/A
#3
$15M376%N/A
#4
$6.9M370%N/A
#5
$8.6M376%N/A